Clinical Trial Compliance & Operations Tech, IRT, RBQM, RTSM

CLINICAL TRIAL COMPLIANCE & OPERATIONS TECHNOLOGY INSIGHTS

Digital Endpoints Are Ready. Clinical Development Isn't
Regulatory guidance and validation science for digital endpoints are solid. The real barrier is cross-functional execution – and the cost of waiting is compounding.
Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
Cleaning data is no longer an afterthought; it’s a continuous, risk-based must-have that protects integrity, ensures compliance, and drives reliable results.

IRT And Direct-To-Patient Trials

Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.
Help Your IRT and eCOA Work Together With The Right Platform Solution

Discover how Suvoda eCOA and IRT, unified on a single, patented platform, streamline clinical trial workflows for sites, sponsors, and CROs.
Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design

Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.

Using Risk-Based Monitoring To Focus On Timelines, Quality, And Budget

Tanya du Plessis, VP of Data Solutions and Strategies at Bioforum, and Rich Davies, VP of Solutions Expert at CluePoints, explain the principle applications of RBQM to Data Management.
RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk

This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.
Five Steps To Streamline Your Trial

Explore the solution for adequately verifying and analyzing data from wearables, remote devices, and other novel data collection modalities.

Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial

Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
IRT: A New Approach To Meeting The Needs Of Early Phase Trials

As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
Is Your Help Desk A Lifeline Or A Landline?

A help desk should accelerate trial success, not create delays. Discover how proactive support and modern tools turn help desks into strategic assets that improve efficiency and reduce risk.

US Healthcare System Overview

A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.
How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).
5 Trends To Watch This Year

Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

When Sites Don't Get Paid

Discover how Greenphire's innovative payment solutions can transform your clinical trial operations and ensure site sustainability.
How Real-World Data On Site Costs Accelerates Clinical Trial Success

Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.
Enhancing Participant Payments: A New Approach

Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.

Automation Is Not Just AI

Hassan Khalid of AstraZeneca and Jessica Jolly, a senior data and science executive, talk about the advantages of automation as a result of a Guidance like ICH M11, and why “automation” is not synonymous with AI in this case.
Can CDOs and CDAOs Evolve From Monotonous SOPs & Reg Filings?

Jessica Jolly, a senior data and science executive, is challenging CDOs (chief data officers) and CDAOs (chief data & analytics officers) to stop putting the data science community “to sleep” with the traditional monotonous SOPs, and instead, move more toward autonomous governance by design.
eISF: Industry Standard eRegulatory Software For Clinical Sites

Modernize your study binder processes with Florence eBinders™, offering remote access for sponsor interactions, monitoring, and source data review.

Streamline Financial Management Of Clinical Trials

Enhance your Clinical Trial Payments solution with IQVIA Forecasting to leverage our global expertise and navigate the complexities of payments with ease.
Greenphire Patient Payments

esigned for sponsors, CROs, sites, and patients, this modern solution delivers real-time data that supports crucial decisions during investigator grant budgeting, randomization, patient payments, and endpoint collection.
Unified Technology To Streamline Clinical Trials

Connect every step of the trial journey with patented data-level integration that links sponsors, sites, and patients.